StonvexLoading…
StonvexCore line items from CFG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.64B | $1.53B | $1.27B | $1.30B |
Operating Income | $2.33B | $1.89B | $2.03B | $2.65B |
Net Income | $1.83B | $1.51B | $1.61B | $2.07B |
EPS (Diluted) | $3.86 | $3.03 | $3.13 | $4.10 |
Total Assets | $226.35B | $217.52B | $221.96B | $226.73B |
Total Liabilities | $200.03B | $193.27B | $197.62B | $203.04B |
Cash & Equivalents | $12.73B | $10.60B | $11.63B | $10.55B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 429.24M | 440.54M | 466.42M | 492.28M |